dyne-tx.com (DYN): Net earnings per share growth forecast for next year

Graphic logo of Dyne Pharma (DYN)

Dyne Therapeutics, Inc. (DYN) generates revenue based on the implementation of FORCE therapy for the treatment of muscle pathologies. On GURU.Markets, the history of consensus earnings estimates for the coming year shows that the indicator stands at 2.90. Unique patents protect the company's developments, creating a significant barrier to entry. Additionally, Dyne Therapeutics, Inc. (DYN) is implementing automated screening systems to accelerate the discovery of new drugs.

Dyne Therapeutics Inc (DYN): Expected net earnings per share growth next year from 07/04/2022 to 11/16/2026

Metric breakdowns and analytics for Dyne Therapeutics (DYN)

General company analysis:Dyne Therapeutics Inc
Brand item of dyne-tx.com

To separate fundamental stability from market noise, it is critical to track the consensus earnings per share (EPS) forecast, which measures the expected net income dynamics for the coming year. By analyzing analysts' 12-month EPS growth targets, an investor can see the monetization potential of the FORCE platform, which provides Dyne Therapeutics, Inc. (DYN) with absolute pricing power due to the unique precision of drug delivery into tissues.

Competitors of Dyne Therapeutics, Inc.

Net earnings per share growth forecast for next year Jazz Pharmaceuticals|CYTK: Expected earnings per share trend next year|Net earnings per share growth forecast for next year PTC Bio (PTCT)|SRRK - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Centessa Pharmaceuticals PLC CNTA|Edgewise Corp - Net earnings per share growth forecast for next year|RAPP - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Alumis Inc.|ZVRA: Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Contineum Pharma CTNM|Expected earnings per share growth for next year LRMR|Expected net earnings per share growth next year Capricor Therapeutics CAPR|Earnings growth forecast for next year TRDA|Expected earnings per share growth for next year Channel Therapeutics PTHS|Earnings growth forecast for next year MNOV (MediciNova)|Expected earnings per share trend next year SER|BTAI - Net earnings per share growth forecast for next year|promisneurosciences.com (PMN) - Expected earnings per share growth for next year|Apimeds (APUS) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year AEON|Net earnings per share growth forecast for next year NLS Pharma|Expected net earnings per share growth next year bionomics.com.au BNOX|Earnings growth forecast for next year HUGE|RETA (Reata Pharma) - Expected earnings per share trend next year